Africa APPG & Global Health APPG - ‘Ebolanomics’, a pharmaceutical question
Royal African Society
0:000:00
Description
The Ebola virus was discovered in 1976 but despite this, no vaccine for the disease is available. It has been suggested that there has been a lack of will to produce a vaccine largely due to Ebola outbreaks tending to occur in poorer countries and that consequently there is limited commercial viability and scope for profit.
This raises a quandary of questions about the interaction between market economics and the pharmaceutical sector that need to be analysed, understood and re-worked into a modern model that responds to the needs of the global population.
Speakers:
Dr. Adesina Iluyemi PhD, NEPAD Council;
Dr. Egeruan Babatunde Imoukhuede, The Jenner Institute at Oxford University;
Mr. Jon Pender, GlaxoSmithKline;
Dr. Adrian Thomas, Janssen Pharmaceutical Companies of Johnson & Johnson.
Remarks: Baroness Northover, Parliamentary Under Secretary of State for DFID
Chair: Meg Hillier MP
